For COVID-19 vaccine updates, please review our information guide and sign up for Connect. Continue your routine care with us by scheduling an in-person appointment or Video Visit.
JRC physician Dr. Robert Battat presented his findings at Digestive Disease Week 2019 demonstrating the efficacy of a serum-based biomarker assay in identifying mucosal inflammation with similar accuracy to fecal calprotectin in patients with Crohn’s disease
